250 related articles for article (PubMed ID: 33490159)
1. Accumulation of TNFR2-expressing regulatory T cells in malignant pleural effusion of lung cancer patients is associated with poor prognosis.
Ye LL; Peng WB; Niu YR; Xiang X; Wei XS; Wang ZH; Wang X; Zhang SY; Chen X; Zhou Q
Ann Transl Med; 2020 Dec; 8(24):1647. PubMed ID: 33490159
[TBL] [Abstract][Full Text] [Related]
2. Interleukin 6 Present in Inflammatory Ascites from Advanced Epithelial Ovarian Cancer Patients Promotes Tumor Necrosis Factor Receptor 2-Expressing Regulatory T Cells.
Kampan NC; Madondo MT; McNally OM; Stephens AN; Quinn MA; Plebanski M
Front Immunol; 2017; 8():1482. PubMed ID: 29163543
[TBL] [Abstract][Full Text] [Related]
3. Expression of TNFR2 by regulatory T cells in peripheral blood is correlated with clinical pathology of lung cancer patients.
Yan F; Du R; Wei F; Zhao H; Yu J; Wang C; Zhan Z; Ding T; Ren X; Chen X; Li H
Cancer Immunol Immunother; 2015 Nov; 64(11):1475-85. PubMed ID: 26280204
[TBL] [Abstract][Full Text] [Related]
4. Increased Regulatory T Cells in Peripheral Blood of Acute Myeloid Leukemia Patients Rely on Tumor Necrosis Factor (TNF)-α-TNF Receptor-2 Pathway.
Wang M; Zhang C; Tian T; Zhang T; Wang R; Han F; Zhong C; Hua M; Ma D
Front Immunol; 2018; 9():1274. PubMed ID: 29922294
[TBL] [Abstract][Full Text] [Related]
5. Th17/Treg imbalance in malignant pleural effusion.
Yang WB; Ye ZJ; Xiang F; Zhang JC; Zhou Q
J Huazhong Univ Sci Technolog Med Sci; 2013 Feb; 33(1):27-32. PubMed ID: 23392703
[TBL] [Abstract][Full Text] [Related]
6. The Significance of Tumor Necrosis Factor Receptor Type II in CD8
Ye LL; Wei XS; Zhang M; Niu YR; Zhou Q
Front Immunol; 2018; 9():583. PubMed ID: 29623079
[TBL] [Abstract][Full Text] [Related]
7. In vitro generated Th17 cells support the expansion and phenotypic stability of CD4(+)Foxp3(+) regulatory T cells in vivo.
Zhou Q; Hu Y; Howard OM; Oppenheim JJ; Chen X
Cytokine; 2014 Jan; 65(1):56-64. PubMed ID: 24080164
[TBL] [Abstract][Full Text] [Related]
8. Interaction of TNF with TNF receptor type 2 promotes expansion and function of mouse CD4+CD25+ T regulatory cells.
Chen X; Bäumel M; Männel DN; Howard OM; Oppenheim JJ
J Immunol; 2007 Jul; 179(1):154-61. PubMed ID: 17579033
[TBL] [Abstract][Full Text] [Related]
9. Treg/Th17 imbalance in malignant pleural effusion partially predicts poor prognosis.
Yang G; Li H; Yao Y; Xu F; Bao Z; Zhou J
Oncol Rep; 2015 Jan; 33(1):478-84. PubMed ID: 25371165
[TBL] [Abstract][Full Text] [Related]
10. MiR-125b-5p modulates the function of regulatory T cells in tumor microenvironment by targeting TNFR2.
Jiang M; Yang Y; Niu L; Li P; Chen Y; Liao P; Wang Y; Zheng J; Chen F; He H; Li H; Chen X
J Immunother Cancer; 2022 Nov; 10(11):. PubMed ID: 36319063
[TBL] [Abstract][Full Text] [Related]
11. The effects of TNF-α/TNFR2 in regulatory T cells on the microenvironment and progression of gastric cancer.
Qu Y; Wang X; Bai S; Niu L; Zhao G; Yao Y; Li B; Li H
Int J Cancer; 2022 Apr; 150(8):1373-1391. PubMed ID: 34766338
[TBL] [Abstract][Full Text] [Related]
12. IRF4 is Correlated with the Conversion to a Th17-Like Phenotype in Regulatory T Cells from the Malignant Pleural Effusion.
Yu W; Ji N; Gu C; Yao J; Ding M; Zhou D; Huang M; Zhang M
Int J Gen Med; 2021; 14():6009-6019. PubMed ID: 34588805
[TBL] [Abstract][Full Text] [Related]
13. TNFR2: Role in Cancer Immunology and Immunotherapy.
Yang Y; Islam MS; Hu Y; Chen X
Immunotargets Ther; 2021; 10():103-122. PubMed ID: 33907692
[TBL] [Abstract][Full Text] [Related]
14. Aberrant frequency of TNFR2-expressing CD4+ FoxP3+ regulatory T cells in nasopharyngeal carcinoma patients.
Engku Abd Rahman ENS; Irekeola AA; Shueb RH; Mat Lazim N; Mohamud R; Chen X; Ghazali L; Awang NMSH; Haron A; Chan YY
Cytokine; 2023 Oct; 170():156341. PubMed ID: 37657236
[TBL] [Abstract][Full Text] [Related]
15. Impaired Th1 immunity in ovarian cancer patients is mediated by TNFR2+ Tregs within the tumor microenvironment.
Govindaraj C; Scalzo-Inguanti K; Madondo M; Hallo J; Flanagan K; Quinn M; Plebanski M
Clin Immunol; 2013 Oct; 149(1):97-110. PubMed ID: 23948613
[TBL] [Abstract][Full Text] [Related]
16. [Level of soluble programmed death ligand 1 in pleural effusion and peripheral blood of patients with tuberculous pleural effusion and its clinical implications].
Pan X; Xing Y; Shi M; Zhou T; Qian B; Chen Y
Zhonghua Yi Xue Za Zhi; 2014 May; 94(20):1543-6. PubMed ID: 25146741
[TBL] [Abstract][Full Text] [Related]
17. Reducing TNF receptor 2+ regulatory T cells via the combined action of azacitidine and the HDAC inhibitor, panobinostat for clinical benefit in acute myeloid leukemia patients.
Govindaraj C; Tan P; Walker P; Wei A; Spencer A; Plebanski M
Clin Cancer Res; 2014 Feb; 20(3):724-35. PubMed ID: 24297862
[TBL] [Abstract][Full Text] [Related]
18. Activated naïve B cells promote development of malignant pleural effusion by differential regulation of T
Wu XZ; Shi XY; Zhai K; Yi FS; Wang Z; Wang W; Pei XB; Xu LL; Wang Z; Shi HZ
Am J Physiol Lung Cell Mol Physiol; 2018 Sep; 315(3):L443-L455. PubMed ID: 29847991
[TBL] [Abstract][Full Text] [Related]
19. Antagonistic Antibody Targeting TNFR2 Inhibits Regulatory T Cell Function to Promote Anti-Tumor Activity.
Chen Y; Jia M; Wang S; Xu S; He N
Front Immunol; 2022; 13():835690. PubMed ID: 35251028
[TBL] [Abstract][Full Text] [Related]
20. Increased soluble and membrane-bound PD-L1 contributes to immune regulation and disease progression in patients with tuberculous pleural effusion.
Pan X; Zhong A; Xing Y; Shi M; Qian B; Zhou T; Chen Y; Zhang X
Exp Ther Med; 2016 Oct; 12(4):2161-2168. PubMed ID: 27698705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]